Skip to content
A Green Sign – Lifestyle
Author:
Mylan Inc.
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
August 24, 2026
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
August 19, 2026
Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium
June 26, 2026
Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium
June 11, 2026
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 18, 2026
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
May 7, 2026
Viatris Reports First-Quarter 2026 Financial Results
May 7, 2026
Viatris Announces Quarterly Dividend
May 5, 2026
Viatris Announces Chief Financial Officer Transition
May 4, 2026
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
April 13, 2026
1
2
Next Page
→